BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
The current student loan debt crisis in the U.S. is real. Total student loan debt currently stands at more than $1.16 trillion. And, according to the Federal Reserve Bank of New York, student loans represent the highest amount of delinquent debt compared to all other forms of household debt, including mortgages, auto loans, and credit cards.
Gaining a college education has long been among the most important first steps towards obtaining a happy and prosperous life. The reality, however, is that most college graduates are starting their adult life deep in debt, and feeling stressed and completely unprepared to manage their financial lives. The good news is that the government has created programs to help borrowers reduce the burden caused by student loan debt. To learn more about these government programs, visit StudentAid.ed.gov.
Money Management International (MMI), along with other nonprofit organizations and consumer advocate groups, have taken additional steps to help struggling student loan borrowers understand their repayment plan options, find solutions for managing other debt obligations, and create realistic action plans for reaching overall financial success.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406151-mmi-student-loan-debt/
The Arthritis Foundation is joining a global effort on Oct. 12, World Arthritis Day, to increase awareness of the many forms of arthritis and to call on individuals and policymakers to take action to reduce the burden of arthritis around the world.
Arthritis affects several hundred million people worldwide. In the United States, it’s the nation’s leading cause of disability, affecting one in five adults (50 million). The disease exacts a hefty financial toll, costing the U.S. economy $128 billion annually. As the staggering prevalence of arthritis continues to rise, the Arthritis Foundation is calling on the nation and individuals to “Move to Improve” to reduce the severe health and economic effects of this disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52066-ad-council-world-arthritis-day-move-to-improve-october-12
Debt is a buzzword for politicians, a burden for students, a necessity for most homeowners and a reality for 70 percent of Americans.
But despite this fact, 30 percent of those in debt have no plan to pay it off, according to a recent survey conducted by Fifth Third Bank (NASDAQ: FITB).
Fifth Third commissioned the national survey to examine the financial beliefs and behaviors of American adults. The results provided a snapshot of our nation’s financial literacy, with 82 percent of respondents citing financial independence as a goal in their lives. The survey also revealed how the three largest generations in America differ in their understanding and management of savings, budgeting, retirement planning and credit.
“At Fifth Third, we were curious to discover how knowledgeable Americans are about their personal finances,” said Jada Grandy, senior vice president and Community Reinvestment Act strategies director, Fifth Third Bank. “The results of this survey give insight into financial literacy in America, as well as the needs of customers at different key stages of their lives. This knowledge arms Fifth Third with the tools to support our customers at every step on their journey to financial independence.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7723851-fifth-third-bank-life/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
Today, politicians, patients and health and work experts of the Fit for Work Europe Coalition added their voices to national advocates from across Europe for their countries to take bold steps to reduce the staggering €240 billion economic burden of chronic musculoskeletal disorders (MSDs) to European society.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/fitforwork/52154/
With the onset of winter season in the country, breathing problems and respiratory diseases will also be on the rise. To ensure that patients with respiratory problems breathe with ease, a comprehensive patient Mobile App named “My Breathefree” has been launched as a virtual caregiver by ‘Breathefree’, a public service initiative by Cipla. This app is specifically designed for Indian conditions and is available on Google play store and iOS platform for all patients, caregivers and doctors.
One of the major chronic respiratory problems in the country is asthma and “My Breathefree” app will be a great help towards better asthma management and control. Asthma causes limitations in daily activities, loss of school and work days, lung function impairment, reduced quality of life and an adverse socioeconomic burden. However, if monitored and treated properly, asthmatics can control their disease and lead an absolutely normal and healthy life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7562351-lung-care-asthma-mobile-app/
We are proud to present the world premiere of Blessed By Burden\'s music video Testament off their new EP \'Addiction.\'
Testament was directed by Brandon Christensen
A majority of U.S. (74 percent) and Canadian (67 percent) finance and accounting executives surveyed recently said they expect their companies’ compliance burden to rise in the coming years, and 48 percent and 41 percent of U.S. and Canadian executives, respectively, also anticipate the cost of compliance will increase. These are just two of the findings from the fifth edition of Benchmarking the Accounting & Finance Function: 2014, an annual study from Robert Half and Financial Executives Research Foundation (FERF), the research affiliate of Financial Executives International (FEI).
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7074551-robert-half-fei-finance-accounting-compliance-burden-research
Beast
of burden. A cover performed by the Swedish duo Wiwa while being filmed
for the swedish television kanal5 at Böda Camping. Originally written
by The Rolling Stones.
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
